Binding Database BindingDB logo

12 articles for thisTarget


PMIDDataArticle TitleOrganization
17887720 4 Macrolactins O-R, glycosylated 24-membered lactones from Bacillus sp. AH159-1.EBI Korea Research Institute of Bioscience and Biotechnology
17201406 31 Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.EBI National de la Recherche Scientifique
15369398 19 Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.EBI The Ohio State University
15006385 36 Identification of novel potent bicyclic peptide deformylase inhibitors.EBI Genomics Institute of the Novartis Research Foundation
14684298 39 Peptide deformylase inhibitors with activity against respiratory tract pathogens.EBI British Biotech Pharmaceuticals Limited
12930137 2 Structure-based design of a macrocyclic inhibitor for peptide deformylase.EBI The Ohio State University
12873500 37 Structure--activity relationships of the peptide deformylase inhibitor BB-3497: modification of the P2' and P3' side chains.EBI British Biotech Pharmaceuticals Limited
12538898 12 Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.BDB GSK
11384231 26 2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.EBI F. Hoffmann-La Roche Ltd.
11378353 14 Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.EBI Pharmacia
10882358 68 Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.EBI F. Hoffmann-La Roche Ltd.
9873565 1 H-phosphonate derivatives as novel peptide deformylase inhibitors.EBI Ohio State University